Cargando…

Invited commentary: When and how to initiate systemic therapy in treating favorable risk metastatic renal cell carcinoma

Detalles Bibliográficos
Autor principal:	Inoue, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Editor Recommendations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772631/ https://www.ncbi.nlm.nih.gov/pubmed/35069079 http://dx.doi.org/10.1097/CU9.0000000000000052

Ejemplares similares

Invited Commentary: Beyond female stress urinary incontinence
por: Bai, Zhiming, et al.
Publicado: (2021)

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
por: Teishima, Jun, et al.
Publicado: (2021)

Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era
por: Shibamori, Kosuke, et al.
Publicado: (2021)

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Machado, P, et al.
Publicado: (2010)

Recommendations Of The Brazilian Society Of Nephrology Regarding Pediatric Patients On Renal Replacement Therapy During The Covid-19 Pandemic
por: Tavares, Marcelo de Sousa, et al.
Publicado: (2020)

Palliative Renal Care and the Covid-19 Pandemic
por: Santos, Cássia Gomes da Silveira, et al.
Publicado: (2020)

Commentary: Bladder cancer
por: Qi, Yingzi, et al.
Publicado: (2021)

EULAR definition of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2021)

Managing Children With Renal Diseases During the COVID-19 Pandemic
por: Vasudevan, Anil, et al.
Publicado: (2020)

Commentary: Treatment of prostate cancer
por: Lyu, Jiaju, et al.
Publicado: (2021)

Treating rheumatoid arthritis to target: the patient version of the international recommendations
por: de Wit, M P T, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Simultaneous laparoscopic nephroureterectomy and robot-assisted radical cystectomy: Lessons learned from our initial experience
por: Yajima, Shugo, et al.
Publicado: (2021)

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2016)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2014)

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function
por: Moura-Neto, José A., et al.
Publicado: (2020)

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
por: Sivera, Francisca, et al.
Publicado: (2014)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
por: Bertsias, George K, et al.
Publicado: (2012)

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Visser, K, et al.
Publicado: (2008)

Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force
por: Smith, Eve Mary Dorothy, et al.
Publicado: (2023)

EULAR recommendations for intra-articular therapies
por: Uson, Jacqueline, et al.
Publicado: (2021)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
por: Torres, Tiago, et al.
Publicado: (2021)

Effect of dipeptidyl peptidase‐4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus
por: Choi, Young, et al.
Publicado: (2023)

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)
por: Pons-Estel, Bernardo A, et al.
Publicado: (2018)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Updated clinical recommendations for the use of tibolone in Asian women
por: Huang, K-E., et al.
Publicado: (2010)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Guidelines for the genetic diagnosis of hereditary recurrent fevers
por: Shinar, Y, et al.
Publicado: (2012)

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

Recommendations on hip fractures
por: Wendt, K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_elkthu6bf39h1g60i0gqc3t5o5